NANOCOMPLEX OF GEFITINIB AND ERLOTINIB FOR ENHANCED LUNG CANCER THERAPY

摘要

The present invention relates to a nanocomplex of gefitinib or erlotinib for enhancing a lung cancer therapy and, more specifically, to a nanocomplex of gefitinib or erlotinib for enhancing a lung cancer therapy, wherein the nanocomplex attaches the gefitinib or the erlotinib used in treating lung cancer to nano materials.